Table 2: OSTI-2369 Trypsin Ki = 0.044 μM
- Measure
- Ki
- Value
- 0.044 µM
- Target
- trypsin
- Assay
- Not reported by source
Biomolecules · 2026
Sequence evidence
ALKRALKRCWTKSIPPRPCFNH
Table 1: OSTI-2369 sequence ALKRALKRCWTKSIPPRPCF-NH2
Experimental observations
Table 2: OSTI-2369 Trypsin Ki = 0.044 μM
Table 3: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739
Table 3: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739
Table 3: OSTI-2369 MIC 8 μM against E. coli BAA 2340
Table 3: OSTI-2369 MBC 8 μM against E. coli BAA 2340
Table 3: OSTI-2369 MIC 8 μM against E. coli NCTC 13846
Table 3: OSTI-2369 MBC 8 μM against E. coli NCTC 13846
Table 3: OSTI-2369 MIC 16 μM against P. aeruginosa ATCC CRM 9027
Table 3: OSTI-2369 MBC 16 μM against P. aeruginosa ATCC CRM 9027
Table 3: OSTI-2369 MIC 32 μM against K. pneumoniae ATCC CRM 43861
Table 3: OSTI-2369 MBC 32 μM against K. pneumoniae ATCC CRM 43861
Table 3: OSTI-2369 MIC 256 μM against A. baumannii BAA 747
Table 3: OSTI-2369 MBC 256 μM against A. baumannii BAA 747
Table 3: OSTI-2369 MIC >512 μM against S. aureus ATCC CRM 6538
Table 3: OSTI-2369 MIC >512 μM against E. faecium NCTC 12697
Table 3: OSTI-2369 MIC 16 μM against MRSA NCTC 12493
Table 3: OSTI-2369 MBC 16 μM against MRSA NCTC 12493
Table 3: OSTI-2369 MIC >512 μM against C. albicans ATCC 10231
Section 3.8: OSTI-2369 produced little haemolysis, less than 10% even at the highest concentrations (1-512 μM) against horse erythrocytes
Section 3.8: OSTI-2369 had minimal impact on HaCaT cell proliferation at 0.1-10 μM but reduced proliferation by more than 20% at 100 μM
Table 4: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 in 1% DMSO (control)
Table 4: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 in 1% DMSO (control)
Table 4: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with FeCl3
Table 4: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 with FeCl3
Table 4: OSTI-2369 MIC 128 μM against E. coli ATCC CRM 8739 with CaCl2
Table 4: OSTI-2369 MBC 128 μM against E. coli ATCC CRM 8739 with CaCl2
Table 4: OSTI-2369 MIC 4 μM against E. coli ATCC CRM 8739 with NaCl
Table 4: OSTI-2369 MBC 4 μM against E. coli ATCC CRM 8739 with NaCl
Table 4: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with KCl
Table 4: OSTI-2369 MBC 16 μM against E. coli ATCC CRM 8739 with KCl
Table 4: OSTI-2369 MIC 16 μM against E. coli ATCC CRM 8739 with MgCl2
Table 4: OSTI-2369 MBC 16 μM against E. coli ATCC CRM 8739 with MgCl2
Table 4: OSTI-2369 MIC 4 μM against E. coli ATCC CRM 8739 with NH4Cl
Table 4: OSTI-2369 MBC 4 μM against E. coli ATCC CRM 8739 with NH4Cl
Table 4: OSTI-2369 MIC 16 μM against E. coli ATCC CRM 8739 with Serum
Table 4: OSTI-2369 MBC 16 μM against E. coli ATCC CRM 8739 with Serum
Table 5: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 (Contrast)
Table 5: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 (Contrast)
Table 5: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with 0.25 mg/mL trypsin
Table 5: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 with 0.25 mg/mL trypsin
Table 5: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with 0.5 mg/mL trypsin
Table 5: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 with 0.5 mg/mL trypsin
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.